Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
The present invention is directed to therapeutic methods that are based
upon an ability to modulate cellular contraction. This is accomplished by
administering agents that either inhibit or induce the activity of
alpha-smooth muscle actin.